Protein Discovery May Explain Why Patients Develop Resistance to New Anti-cancer Drugs

A team of researchers have identified a protein complex that might explain why some cancer patients treated with revolutionary new anti-cancer drugs, known as PARP inhibitors, develop resistance to their medication.